Showing results (241-250 of 365) with videos related to

Sort By:
Pageof 37
American Journal of Clinical Oncology|February 4, 2014
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality TherapyGrace J Kim, Matthew Koshy, Alexandra L Hanlon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 2, 2019
Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patientsLaurie E Steffen, Jennifer S Cheavens, Kevin E Vowles, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancerMartin J Edelman, Chandra P Belani, Mark A Socinski, et al.
Nature Communications|October 15, 2021
Individualised and non-contact post-mortem interval determination of human bodies using visible and thermal 3D imagingLeah S Wilk, Gerda J Edelman, Martin Roos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
RB status as a determinant of response to UCN-01 in non-small cell lung carcinomaP C Mack, D R Gandara, C Bowen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancerK M Kerr, L Bubendorf, M J Edelman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccineKati J Edelman, Qiushui He, Johanna P Makinen, et al.
Bioorganic & Medicinal Chemistry|January 8, 2013
Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepinesAtul Kondaskar, Shilpi Kondaskar, James C Fishbein, et al.
Cancer|August 10, 1999
Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndromeM J Edelman, D R Gandara, F J Meyers, et al.
Pageof 37